Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine Pharmacokinetics and Dynamics in Obesity and Obstructive Sleep Apnoea
2022-500779-29-00Phase 2Completed
- Sponsor
- Hospital of South West Jutland
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of morphine in obesity and obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Hospital of South West Jutland. Primary endpoints: Morphine AUC and Morphine Cmax. Started Sep 2022; status: completed.
02
Drugs
morphine
03
Conditions
obesityobstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on 2022-500779-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500779-29-00.